Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2331059 Target Snapshot

Delta(24)-sterol reductase · SINGLE PROTEIN · Homo sapiens

276Compounds
8Assays
1Approved Drugs
267.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q15392. Use UniProt Q15392 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q15392 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Delta(24)-sterol reductase as ChEMBL target CHEMBL2331059, mapped to UniProt Q15392. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Delta(24)-sterol reductase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2331059
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q15392
Delta(24)-sterol reductase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Delta(24)-sterol reductase is the right protein anchor across sources, using UniProt Q15392 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDelta(24)-sterol reductase
UniProt AccessionQ15392
Component TypeProtein
Sequence Length516 aa

Delta(24)-sterol reductase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Delta(24)-sterol reductase, mapped to UniProt Q15392. Sequence length is 516 aa.

Mapped IDQ15392
Review nameDelta(24)-sterol reductase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5028.0
KD239.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4164183 10.0 IC50 0.1 Preclinical
CHEMBL352837 9.15 IC50 0.7 Preclinical
CHEMBL4174848 8.6 IC50 2.5 Preclinical
CHEMBL4170755 8.54 IC50 2.9 Preclinical
CHEMBL4164005 8.48 IC50 3.3 Preclinical
CHEMBL4167637 8.38 IC50 4.2 Preclinical
CHEMBL4159728 8.26 IC50 5.5 Preclinical
CHEMBL4164428 8.2 IC50 6.3 Preclinical
CHEMBL4167452 6.7 IC50 198.0 Preclinical
CHEMBL4172305 6.69 IC50 203.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
3
6.0
2
6.5
0
7.0
0
7.5
4
8.0
2
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

GILTERITINIB
CHEMBL3301622
Approved 2018
Assay Landscape

Assay Landscape

8
Total Assays
15
Tested Compounds
1
Assay Types
Binding — 8 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 13 7.7
single protein format 3 1 4.4
subcellular format 2 1 6.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine